A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

A study by University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue ...

By trawling through databases of RNA sequences based on models of intestinal damage, a team of researchers led by scientists ...

Lutikizumab is under clinical development by AbbVie and currently in Phase II for Crohn's Disease (Regional Enteritis).

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

Tulisokibart is under clinical development by Merck and currently in Phase III for Crohn's Disease (Regional Enteritis).

Four years ago, over dinner and drinks, five Buckhead moms hatched a bold plan to turn their love of softball into a lifeline for those battling Crohn’s disease.

A device used in South Jersey is a game-changer for people with inflammatory bowel disease as an alternative to invasive ...

Nutrients specific to the Mediterranean diet could help with symptom management in inflammatory bowel disease, evidence ...